Bayer CropScience Ltd Q2 FY26 results (latest), Jul–Sep 2025 →Revenue ₹1,553 Cr −10.6% YoYSee revenue, profit and what management said. You are viewing Q4 FY18.
BC

Bayer CropScience Ltd

Q4 FY18Fertilizers & Agrochemicals

Bayer CropScience Q4 FY18 earnings call: Revenue & Margins

Q4 FY18 investor presentation: what the company reported on revenue, margins and capex.

Bayer CropScience Ltd Q4 FY18 key numbers

Revenue
Sales for Bayer Global Q1 2018 were €9,138 million.

As stated in Bayer CropScience Ltd's Q4 FY18 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.

Based on Bayer CropScience Ltd's Q4 FY18 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹3,736
Market cap₹17.0K Cr
P/E23.2

The short version

Sales for Bayer Global Q1 2018 were €9,138 million. EBITDA (before special items) for Bayer Global in Q1 2018: - Crop Science segment: €2,861 million, down 1.0% year-on-year (currency- and portfolio-adjusted) - Operating margin: - Crop Science segment declined by 6.5% in Q1 2018 year-on-year - Profit (PAT) for Financial Year 2017-18 (not quarter): - Profit Before Tax (PBT) decreased 9% over previous year; figures: PY 4,479 Mio INR, CY 4,038 Mio INR

From Bayer CropScience Ltd's Q4 FY18 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Sales for Bayer Global Q1 2018 were €9,138 million.
  • Year-on-year change (currency- and portfolio-adjusted):
  • Consumer Health: -2.2%
  • Crop Science: -1.0%
  • Animal Health: +3.0%
  • Pharmaceuticals: +2.9%
  • EBITDA changes year-on-year:
  • Pharmaceuticals: -5.8%
  • Consumer Health: -20.2%
  • Crop Science: -6.5%
  • Animal Health: +3.0%
  • Income overview for FY 2017-18:
  • Total revenue decreased from INR 30,185 million (PY) to INR 27,878 million (CY).
  • Exports contribution to revenue decreased from 14% to 9%.
  • Domestic contribution increased from 81% to 86%.
  • Outlook (Page 27 & 31):
  • Positive outlook for 2018-19 based on good monsoon forecast.
  • Expectation of positive commodity prices in 2018.

2 more points from Bayer CropScience Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Bayer CropScience Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

It focuses primarily on business updates, portfolio pipeline, integration opportunities with Monsanto, product pipelines, pilot project progress, and financial highlights without mentioning dedicated capital expenditure plans or plant expansions.

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Bayer CropScience Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Key points relevant to business performance and outlook include: - Confidence in seeds and crop protection (CP) business based on a good monsoon forecast (Page 31 Summary). - Strong portfolio pipeline to capture new segments and opportunities (Page 31). - Continuous efforts to increase agricultural productivity sustainably and improve lives of families and communities (Pages 29 and 31).

2 more points from Bayer CropScience Ltd's call on order book

Create a free account to keep reading this call

Bayer CropScience Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.1K Cr, net profit ₹162 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Bayer CropScience Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Bayer CropScience Ltd Q4 FY18 results?

Sales for Bayer Global Q1 2018 were €9,138 million. EBITDA (before special items) for Bayer Global in Q1 2018: - Crop Science segment: €2,861 million, down 1.0% year-on-year (currency- and portfolio-adjusted) - Operating margin: - Crop Science segment declined by 6.5% in Q1 2018 year-on-year - Profit (PAT) for Financial Year 2017-18 (not quarter): - Profit Before Tax (PBT) decreased 9% over previous year; figures: PY 4,479 Mio INR, CY 4,038 Mio INR

What is Bayer CropScience Ltd share price analysis?

Bayer CropScience Ltd currently shows a neutral. The stock trades at a P/E of 23.2 with a market cap of ₹16,986 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Bayer CropScience Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.